Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection | NEJM
Tuberculosis Series: Treatment - EthnoMed
Table 3 from Treatment of Latent Tuberculosis Infection. | Semantic Scholar
Treatment Regimens for Latent TB Infection | TB | CDC
Rifapentine Dosing for Children With Latent Tuberculosis Infection in... | Download Table
LTBI | Features | TB | CDC
3HP for Latent TB Infection Treatment | CDC
A Lazy Person's Guide to Latent Tuberculosis Treatment in Patients with HIV - Southeast AIDS Education & Training Center
Twelve-dose weekly rifapentine plus isoniazid for latent tuberculosis infection: A multicentre randomised controlled trial in Taiwan - ScienceDirect
Treatment for Latent TB Infection in Adults | Download Table
Cureus | Use of Isoniazid Monotherapy in Comparison to Rifamycin-Based Regimen for the Treatment of Patients With Latent Tuberculosis: A Systematic Review | Article
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries | European Respiratory Society
12-dose Isoniazid/Rifapentine Regimen for Latent TB Infection Treatment | National Prevention Information Network | Connecting public health professionals with trusted information and each other
PDF] Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy | Semantic Scholar
Identification and Management of Latent Tuberculosis Infection | AAFP
Benefit of treatment of latent tuberculosis infection in individual patients | European Respiratory Society
3HP for Latent TB Infection Treatment | CDC
Treatment for Latent Tuberculosis (TB) Infection: Isoniazid and Rifapentine (INH-RPT) | National Prevention Information Network | Connecting public health professionals with trusted information and each other
What You Need to Know About Your Medicine for Latent Tuberculosis (TB) Infection – Isoniazid and Rifapentine | National Prevention Information Network | Connecting public health professionals with trusted information and each other
Treatment options for latent tuberculosis infection - Latent tuberculosis infection: updated and consolidated guidelines for programmatic management - NCBI Bookshelf